Skip to main content
. 2020 Apr 23;55:102755. doi: 10.1016/j.ebiom.2020.102755

Fig. 4.

Fig 4

Progression-free survival (PFS, 4a) and overall survival (OS, 4b) analysis according to the dose level of CM082 with everolimus (n = 19).